hotspot -WSS

hotspot

author：explore 2025-10-02 22:57:21 - browse：6723

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Eliminate the waiting period for sterilization covered by Medicaid

Wikipedia

explore

WSS

Merck drug for rare lung condition set for approval in U.S.

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Decaf coffee targeted by food safety group under obscure FDA rule

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Dogs on Prozac: What pet anti

Study says nonprofit hospitals fall short in charity care spending

focus

hotspot

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Getting Alzheimer's drug Leqembi to patients can be a challenge

Hepatitis C has a cure — but many Americans still lack access to it

Eliminate the waiting period for sterilization covered by Medicaid

Wildfire smoke exposes gaps in outdoor worker protections

Study says nonprofit hospitals fall short in charity care spending

Activists slam private health insurers over coverage restrictions

Diversity in clinical trials starts with building trust, experts say

Supreme Court strikes down use of affirmative action

Q&A: Jennifer Adair on making gene therapy available globally

focus

H5N1 bird flu virus started spreading in cows in Texas in December

Key Senate committee drafts bipartisan bill to stem drug shortages

Bird flu outbreak in cows is latest avian flu curveball

Orangutan used medicinal plant to treat wound, first time ever seen

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Vertex Pharmaceuticals may move headquarters in Boston

explore

Wikipedia

explore

Wikipedia